Polaris Venture Management Co. V as of Dec. 31, 2018
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 12 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cardlytics (CDLX) | 29.5 | $28M | 2.6M | 10.83 | |
| Fate Therapeutics (FATE) | 25.0 | $23M | 1.8M | 12.83 | |
| Neuronetics (STIM) | 17.0 | $16M | 825k | 19.35 | |
| Kala Pharmaceuticals | 9.7 | $9.1M | 1.9M | 4.89 | |
| T2 Biosystems | 5.9 | $5.5M | 1.8M | 3.01 | |
| Arsanis | 4.6 | $4.3M | 1.9M | 2.32 | |
| Selecta Biosciences | 4.6 | $4.3M | 1.6M | 2.66 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 1.0 | $914k | 1.8M | 0.50 | |
| Trevena | 0.9 | $883k | 2.1M | 0.43 | |
| Pulmatrix | 0.9 | $863k | 3.6M | 0.24 | |
| Genocea Biosciences | 0.6 | $571k | 2.0M | 0.29 | |
| Dare Bioscience | 0.2 | $232k | 326k | 0.71 |
